241344836 torch in pregnancy
DESCRIPTION
torchTRANSCRIPT
-
INFECTION IN PREGNANCY
TORCH
-
Horizontal transmission
Vertical transmission
Congenital infection
Perinatal infection
Neonatal infection
Postnatal infection
Mode of Transmission
-
Infection during pregnancy:
Transplacental infection
Non placental infection:
Ascending infection
Intrapartum infection
Postnatal infection
-
General Principles
Pregnancy does not alter resistance to infection
Severe infections have greater effects on the fetus
Maternal antibodies cross the placenta and give passive immunity to the fetus
Fetus becomes immunologically competent from the 14th week
-
Fetus and Infection
Indirect effect - O2 transport, nutrient exchangeDirect effect - invasion of placenta and infection of fetusViruses more than bacteriararely effect fetus unless maternal infection is severeexception: Rubella, CMV, Herpes Simplex -
Fetus and Infection
Infections cause
- miscarriage
- congenital anomalies
- fetal hydrops
- fetal death
- preterm delivery
- preterm rupture of the membranes
-
TORCH
T = Toxoplasma gondii
O= Others
R= Rubella Virus
C= Cytomegalovirus
H= Herpes Simplex Virus
-
Toxoplasmosis
Caused by protozoan Toxoplasma gondiiDomestic cat is the definitive host with infections via:Ingestion of cysts (meats, garden products)Contact with oocysts in fecesMuch higher prevalence of infection in European countries (ie France, Greece)Acute infection usually asymptomatic1/3 risk of fetal infection with primary maternal infection in pregnancyInfection rate higher with infxn in 3rd trimesterFetal death higher with infxn in 1st trimester -
Toxoplasma Infection
Acquired infection
immunocompetent individuals:
Asymptomatic or very mild infection
immunocompromised individuals:
high risk of fatal disseminated infection;
often reactivation
Congenital infection (in pregnancy):
- high risk of fetal damage or death after
- primary infection during pregnancy
-
Risk Factors for Congenital Toxoplasmosis
Primary Toxoplasma infection during pregnancy:
no known risk for congenital infection of infants born to immune women
no known risk of congenital infection in case of primary infection before conception
-
Time point of infection during pregnancy
-
Clinical Manifestations
Most (70-90%) are asymptomatic at birthClassic triad of symptoms:ChorioretinitisHydrocephalusIntracranial calcificationsOther symptoms include fever, rash, HSM, microcephaly, seizures, jaundice, thrombocytopenia, lymphadenopathy, premature-birth, still-birth/IUFDInitially asymptomatic infants are still at high risk of developing abnormalities, especially chorioretinitis -
Chorioretinitis of congenital toxo
-
Diagnosis
Maternal IgG testing indicates past infection (but when?)Can be isolated in culture from placenta, umbilical cord, infant serumPCR testing on WBC, CSF, placentaNot standardized -
Toxo Screening
Prenatal testing with varied sensitivity not useful for screeningNeonatal screening with IgM testing implemented in some areasIdentifies infected asymptomatic infants who may benefit from therapy -
Treatment
Treatment for pregnant mothers diagnosed with acute toxoSpiramycin dailyMacrolide antibioticSmall studies have shown this reduces likelihood of congenital transmission (up to 50%)If infant diagnosed prenatally, treat momSpiramycin, pyrimethamine (anti-malarial, dihydrofolate reductase inhib), and sulfadiazine (sulfa antibiotic)Leucovorin rescue with pyrimethamine -
Syphilis
T.Pallidum -
Syphilis
Treponema pallidum (spirochete)Transmitted via sexual contactPlacental transmission as early as 6wks gestationTypically occurs during second halfMom with primary or secondary syphilis more likely to transmit than latent diseaseLarge decrease in congenital syphilis since late 1990sIn 2002, only 11.2 cases/100,000 live births reported -
Congenital Syphilis
2/3 of affected live-born infants are asymptomatic at birthClinical symptoms split into early or late (2 years is cut off)3 major classifications:Fetal effectsEarly effectsLate effects -
Clinical Manifestations
Fetal:StillbirthNeonatal deathHydrops fetalisIntrauterine death in 25%Perinatal mortality in 25-30% if untreated -
Clinical Manifestations
Early congenital (typically 1st 5 weeks):Cutaneous lesions (palms/soles)HSMJaundiceAnemiaSnufflesPeriostitis and metaphysial dystrophyFunisitis (umbilical cord vasculitis) -
Periostitis of long bones seen in neonatal syphilis
-
Clinical Manifestations
Late congenital:Frontal bossingShort maxillaHigh palatal archHutchinson teeth8th nerve deafnessSaddle nose Perioral fissuresCan be prevented with appropriate treatment -
Hutchinson teeth late result of congenital syphilis
-
Diagnosing Syphilis
Available serologic testingRPR/VDRL: nontreponemal testSensitive but NOT specificQuantitative, so can follow to determine disease activity and treatment responseMHA-TP/FTA-ABS: specific treponemal testUsed for confirmatory testingQualitative, once positive always positiveRPR/VDRL screen in ALL pregnant women early in pregnancy and at time of birthThis is easily treated!!
(Not in Newborns) -
Definition of Congenital Syphilis
Confirmed if T. pallidum identified in skin lesions, placenta, umbilical cord, or at autopsyPresumptive diagnosis if any of:Physical exam findingsCSF findings (positive VDRL)Osteitis on long bone x-raysFunisitis (barber shop pole umbilical cord)RPR/VDRL >4 times maternal testPositive IgM antibody -
Treatment
Penicillin G is THE drug of choice for ALL syphilis infectionsMaternal treatment during pregnancy very effective (overall 98% success)Treat newborn if:They meet CDC diagnostic criteriaMom was treated -
Rubella
Togavirus: single-stranded RNA virusIncubation - 14-21 daysRespiratory droplet inoculationonly modestly contagiousFever, rash (3 days), cough, arthralgias, post auricular and suboccipital lymphadenopathyUsually mild, overt clinical symptoms 50-75% of casesEncephalitis, bleeding diathesis & arthritis are rare complicationsInfection earlier in pregnancy has a higher probability of affected infant - Sensorineural hearing loss (50-75%)Cataracts and glaucoma
(20-50%)Cardiac malformations (20-50%)Neurologic (10-20%)Others to
include growth retardation, bone disease, HSM, thrombocytopenia,
blueberry muffin lesions
Rubella and the Fetus
-
Blueberry muffin spots representing
extramedullary hematopoesis
- Purpura, Splenomegaly, jaundice, meningoencephalitis, thrombocytopenia are transientCongenital cataracts, Glaucoma, heart disease, deafness, microcephaly and mental retardation are permanent abnormalitiesSequele: Diabetes, thyroid abnormalities, precocious puberty & progressive panencephalitis
-
Diagnosis
Maternal IgG may represent immunization or past infection - Useless!Can isolate virus from nasal secretionsLess frequently from throat, blood, urine, CSFSerologic testingIgM = recent postnatal or congenital infectionRising monthly IgG titers suggest congenital infectionDiagnosis after 1 year of age difficult to establish -
Prevention and Treatment
Vaccination (95% seroconversion)@ 15 months and early adulthood
Immune status checking in teenagers, pre-college and pre-pregnancy Antenatal testingSerology testing for presumed exposures (paired Sera)No in-utero therapy -
Cytomegalovirus
DNA virusCongenital infection - 1%5-10% of those infected show clinical illness at birthNeonatal MR - 20-30%90% of survivors get late complications5-15% with no demonstrable disease at birth get some abnormality (deafness) -
Cytomegalovirus (CMV)
Most common congenital viral infection~40,000 infants per year in the U.S.Mild, self limiting illnessTransmission can occur with primary infection or reactivation of virus40% risk of transmission in primary infxnStudies suggest increased risk of transmission later in pregnancyHowever, more severe sequalae associated with earlier acquisition -
Clinical Manifestations
90% are asymptomatic at birth!Up to 15% develop symptoms later, notably sensorineural hearing lossSymptomatic infectionSGA, HSM, petechiae, jaundice, chorioretinitis, periventricular calcifications, neurological deficits>80% develop long term complicationsHearing loss, vision impairment, developmental delay -
CMV Congenital Infection
Hepatomegaly}Spleenomegaly}Jaundice}TORCHThrombocytopenia}SyndromePetechiae}Microcephaly}Intrauterine growth retardation} -
CMV Congenital Infection (Late)
VenticulomegalyCerebral atrophyMental retardationPsychomotor delaySeizuresLearning difficulties and language delayChorioretinitis / Optic atrophyIntracranial calcificationsLong bone radiolucencies, dental abnormalitiesPneumonitis -
Ventriculomegaly and calcifications of congenital CMV
-
Diagnosis
Maternal IgG shows only past infectionInfection common this is uselessViral isolation from urine or saliva in 1st 3weeks of lifeAfterwards may represent post-natal infectionViral load and DNA copies can be assessed by PCRLess useful for diagnosis, but helps in following viral activity in patientSerologies not helpful given high antibody in population -
Treatment
Ganciclovir 6wks in symptomatic infantsStudies show improvement or no progression of hearing loss at 6mosNo other outcomes evaluated (development, etc.)Neutropenia often leads to cessation of therapyTreatment currently not recommended in asymptomatic infants due to side effectsArea of active research to include use of valgancyclovir, treating asymptomatic patients, etc.No vaccination -
Herpes Simplex (HSV)
HSV1 or HSV2Primarily transmitted through infected maternal genital tractRationale for C-section delivery prior to membrane rupturePrimary infection with greater transmission risk than reactivation -
Clinical Manifestations
Most are asymptomatic at birth3 patterns of ~ equal frequency with symptoms between birth and 4wks:Skin, eyes, mouth (SEM)CNS diseaseDisseminated disease (present earliest)Initial manifestations very nonspecific with skin lesions NOT necessarily present -
Presentations of congenital HSV
-
Diagnosis
Culture of maternal lesions if present at deliveryCultures in infant:Skin lesions, oro/nasopharynx, eyes, urine, blood, rectum/stool, CSFCSF PCRSerologies again not helpful given high prevalence of HSV antibodies in population -
*
-
Treatment
High dose acyclovir 60mg/kg/day divided q8hrsX21days for disseminated, CNS diseaseX14days for SEMOcular involvement requires topical therapy as well -
Index of Suspicion
When do you think of TORCH infections?IUGR infantsHSMThrombocytopeniaUnusual rashConcerning maternal historyClassic findings of any specific infection -
Conclusion
The main issues include
General principlesInfection and the fetal affectsSpecific problems for the fetus with maternal infections.Congenital syndromes - main features -
Which TORCH Infections Can Absolutely Be Prevented?
RubellaSyphilis